Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.800
-0.040 (-2.17%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or -1.73% compared to the previous year.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$535,660
Profits / Employee
-$119,067
Market Cap
231.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 854 | -15 | -1.73% |
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Emergent BioSolutions | 900 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| ADC Therapeutics | 193 |
| Alpha Teknova | 158 |
ORGO News
- 16 days ago - Organogenesis price target lowered to $2 from $3 at Truist - TheFly
- 16 days ago - Organogenesis Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Organogenesis Holdings Earnings release: Q2 2026 - Filings
- 16 days ago - Organogenesis Holdings Quarterly report: Q2 2026 - Filings
- 16 days ago - Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 26 days ago - Organogenesis Affinity meets primary endpoint in complex venous leg ulcer trial - TheFly
- 26 days ago - Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - GlobeNewsWire
- 6 weeks ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - GlobeNewsWire